The U.S. Food and Drug Administration says they are still reviewing reports about the possibility that the diabetes drug Avandia raises the risk of heart attack, and whether or not the drug should have been pulled from the market. The FDA is reviewing several studies, including the RECORD study, to determine if the drug is safe.
Read full story >